This inventor holds 7 USPTO granted patents. Top assignee: The University of British Columbia. Active years: 2002-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Redland, IE (2007)
- Redland, GB (2002 - 2011)
Company Filing History:
Years Active: 2002-2011
Title: Brendan Kenny - Innovator in Pathogenic Biology
Introduction
Brendan Kenny, a prominent inventor based in Redland, GB, has made significant advancements in the field of pathogenic biology. With a total of seven patents to his name, his work focuses on understanding and diagnosing diseases caused by enteropathogenic and enterohemorrhagic bacteria.
Latest Patents
Among his latest innovations, Brendan has developed a polypeptide named EspA, which is secreted by pathogenic bacteria, including enteropathogenic (EPEC) and enterohemorrhagic (EHEC) strains. This invention involves isolated nucleic acid sequences encoding the EspA polypeptide, recombinant methods for producing it, and kits for detecting EspA-producing hosts.
Additionally, he has contributed to the understanding of the Tir (translocated intimin receptor) polypeptide, which these pathogens utilize to adhere to mammalian cells. His work not only provides methods for diagnosing diseases through antibodies and nucleic acid probes but also includes immunization strategies to induce protective immune responses against Tir.
Career Highlights
Brendan Kenny works at the University of British Columbia, where he continues to push the boundaries of research in pathogenic biology. His expertise in this field has led to groundbreaking inventions that contribute significantly to medical science and the treatment of bacterial infections.
Collaborations
In his research endeavors, Brendan collaborates with esteemed colleagues such as Markus Stein and B. Brett Finlay. Together, they form a team dedicated to unraveling the complexities of bacterial pathogenesis and developing innovative solutions to combat bacterial diseases.
Conclusion
Brendan Kenny's contributions as an inventor in the realm of pathogenic biology exemplify the impact of innovative research on healthcare. With his continued dedication to advancing our understanding of bacterial interactions and disease mechanisms, his inventions will likely yield critical insights for future medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile